Left Menu
Development News Edition

Delhi-based Dr. Dang's lab partners with Bharat Biotech for human clinical trials of Covaxin

Delhi-based Dr. Dangs Lab has been selected to partner with Hyderabad-based Bharat Biotech for the human clinical trials of Covaxin, India's indigenous COVID-19 vaccine.

ANI | New Delhi | Updated: 22-07-2020 20:32 IST | Created: 22-07-2020 20:32 IST
Delhi-based Dr. Dang's lab partners with Bharat Biotech for human clinical trials of Covaxin
Representative Image. Image Credit: ANI

Delhi-based Dr. Dangs Lab has been selected to partner with Hyderabad-based Bharat Biotech for the human clinical trials of Covaxin, India's indigenous COVID-19 vaccine. Bharat Biotech is a leading biotechnology company that creates effective vaccines and bio-therapeutics for patients around the world.

"We are extremely privileged to announce that Dr. Dangs Lab, New Delhi has been provided the opportunity to serve the nation by being selected as the central lab for the Human Clinical trials of Covaxin. This is a randomised, double blind, placebo controlled multi centric clinical trial in India," Dr. Dangs Lab said in a statement to ANI. The lab is currently processing all samples for screening and safety for the various phases of this clinical trial, whereas all the efficacy studies will be performed in NIV (Pune).

The lab said it has already started receiving samples from 50 to 100 subjects per day from various trial sites for safety testing and will be increasing operations as per assigned timelines to cover 12 sites across the length and breadth of the country over this month. "Stringent quality norms driven by GCLP guidelines are being followed as mandated by regulatory authorities. The lab has renowned experts in each field who are working tirelessly and collectively to provide quality and timely results to fulfill the imminent need of an effective and safe COVID19 vaccine," it said.

Drug Controller General of India (DCGI) had recently gave a green signal for human clinical trials for COVID-19 vaccine candidate Covaxin, which has been developed by the Hyderabad-based Bharat Biotech in collaboration with the ICMR and the National Institute of Virology (NIV). Earlier in April, Dr. Dangs Lab also became the first lab in the country to start India's first drive-through testing facility for COVID-19.

"Due to COVID-19 cases surging in Delhi-NCR, we started this novel initiative of drive-through testing and we've now established our third facility. This initiative was planned keeping in mind the increasing number of cases and also increase in demand for testing. Anyone with mild or moderate symptoms of COVID-19 can get their test done at this drive-through facility," Dr Arjun Dang, CEO of Dr Dangs Lab told ANI. "A 20-minute time slot is allocated to each vehicle, but the entire sample collection process lasts for not more than 6-7 minutes. We have kept a buffer period to avoid overcrowding and overlapping. Also, we will have sufficient time to sanitise the place to maintain the highest levels of safety and hygiene for everyone using the facility," he said

After collecting nearly 3,000 samples with the help of its facilities in Punjabi Bagh and Saket, Dr Dangs Lab has opened another centre near Siri Fort Auditorium in the national capital. (ANI)



Post-COVID-19 Nigeria needs a robust Health Management Information System to handle high disease burden

Nigeria is among a few countries that conceptualised a health management information system HMIS in the early 90s but implementation has been a challenge till date. Besides COVID-19, the country has a huge burden of communicable and non-com...

Morocco COVID-19 response: A fragile health system and the deteriorating situation

Learning from its European neighbors, Morocco imposed drastic measures from the initial stages of the COVID-19 outbreak to try to contain its spread. The strategy worked for a few months but the cases have surged after mid-June. In this sit...

COVID-19: Argentina’s health system inefficiencies exaggerate flaws of health information system

You can recover from a drop in the GDP, but you cant recover from death, was the straightforward mindset of Argentinas President Alberto Fernndez and defined the countrys response to COVID-19. The South American nation imposed a strict...

Rwanda’s COVID-19 response commendable but health information system needs improvement

Rwanda is consistently working to improve its health information system from many years. However, it is primarily dependent on the collection and reporting of health data on a monthly basis. Besides, evaluation studies on Rwandas HIS publis...


Latest News

Olympics-Tokyo organisers outline steps for 'simplified' Games

Organisers of the Tokyo Olympics on Friday proposed a raft of measures to hold a streamlined Summer Games next year, including a shorter opening period for training venues and scaling back staff for the torch relay.The Games, originally sch...

Cabinet reiterates determination to fight GBVF by strengthening law

Cabinet has reiterated its determination to fight gender-based violence and femicide GBVF by strengthening the law and providing psychosocial support and advocacy programmes within communities. Based on data obtained through the South Afric...

Soccer-Messi lashes out at Barca over Suarez departure

Lionel Messi has launched his latest attack on Barcelonas hierarchy by criticising the way the club treated strike partner Luis Suarez, who left for La Liga rivals Atletico Madrid this week. Captain Messi, who threatened to leave Barca last...

Hong Kong student faces charges of inciting secession- police

A student arrested in Hong Kong on suspicion of selling weapons online faces charges of inciting secession under a security law imposed on the city by China three months ago, a senior police officer said on Friday. Police arrested the 23-ye...

Give Feedback